FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210473220> ?p ?o ?g. }

• W4210473220 endingPage "102352" @default.
• W4210473220 startingPage "102352" @default.
• W4210473220 abstract "The addition of immune checkpoint inhibitors (ICI) to chemotherapy (CT) has been one of the main clinical research endeavors over the last few years in patients with metastatic triple-negative breast cancer (TNBC). Recent randomized controlled trials (RCTs) have presented heterogeneous results that have elicited discussion in the oncology community. Here we conducted a systematic review and meta-analysis to evaluate this strategy.A systematic literature review was conducted to identify RCTs that evaluated the combination of ICI plus CT versus CT alone in untreated metastatic TNBC. Random effects models were used to estimate pooled hazard ratios (HR) and odds ratios with 95% confidence intervals (95 %CI).A total of three RCTs including 2,400 patients with TNBC met the eligibility criteria. Patients with PD-L1-positive tumors had a significantly better PFS with the addition of ICI (HR = 0.67; 95 %CI: 0.58-0.79) and a trend towards better OS (HR = 0.79; 95 %CI: 0.60-1.03), while no benefit was observed in patients with PD-L1-negative tumors. In the PD-L1-positive subgroup, no relevant differences were found according to taxane agent used, ECOG performance status or number of metastatic sites. However, CT naïve patients obtained a larger benefit with ICI (PFS HR = 0.53) than patients previously treated with CT in neoadjuvant/adjuvant setting (PFS HR = 0.81). The most frequent immune-related adverse events in patients receiving ICI were hypothyroidism (16%) and hyperthyroidism (4.9%).ICI plus CT improves PFS and OS in PD-L1-positive population. A greater benefit in CT naïve patients was observed for the PD-L1-positive population while no difference was observed between taxane regimes used." @default.
• W4210473220 created "2022-02-08" @default.
• W4210473220 creator A5008566812 @default.
• W4210473220 creator A5028946644 @default.
• W4210473220 creator A5043895722 @default.
• W4210473220 creator A5045644790 @default.
• W4210473220 creator A5053324492 @default.
• W4210473220 creator A5058837514 @default.
• W4210473220 creator A5087015760 @default.
• W4210473220 creator A5089555041 @default.
• W4210473220 date "2022-03-01" @default.
• W4210473220 modified "2023-10-13" @default.
• W4210473220 title "Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis" @default.
• W4210473220 cites W1964814702 @default.
• W4210473220 cites W1994993231 @default.
• W4210473220 cites W2007679672 @default.
• W4210473220 cites W2097200850 @default.
• W4210473220 cites W2098923148 @default.
• W4210473220 cites W2100413206 @default.
• W4210473220 cites W2103563357 @default.
• W4210473220 cites W2111495238 @default.
• W4210473220 cites W2112434826 @default.
• W4210473220 cites W2114505219 @default.
• W4210473220 cites W2134539328 @default.
• W4210473220 cites W2731921472 @default.
• W4210473220 cites W2803583824 @default.
• W4210473220 cites W2805354595 @default.
• W4210473220 cites W2889746019 @default.
• W4210473220 cites W2890298773 @default.
• W4210473220 cites W2897422388 @default.
• W4210473220 cites W2902530914 @default.
• W4210473220 cites W2902655481 @default.
• W4210473220 cites W2965019135 @default.
• W4210473220 cites W2989792268 @default.
• W4210473220 cites W2990398119 @default.
• W4210473220 cites W3006693642 @default.
• W4210473220 cites W3006930853 @default.
• W4210473220 cites W3009486036 @default.
• W4210473220 cites W3033712936 @default.
• W4210473220 cites W3087393791 @default.
• W4210473220 cites W3096112873 @default.
• W4210473220 cites W3109853980 @default.
• W4210473220 cites W3127482120 @default.
• W4210473220 cites W3172355022 @default.
• W4210473220 cites W3173705400 @default.
• W4210473220 cites W3175173749 @default.
• W4210473220 cites W3176200586 @default.
• W4210473220 cites W4294215472 @default.
• W4210473220 doi "https://doi.org/10.1016/j.ctrv.2022.102352" @default.
• W4210473220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35144055" @default.
• W4210473220 hasPublicationYear "2022" @default.
• W4210473220 type Work @default.
• W4210473220 citedByCount "14" @default.
• W4210473220 countsByYear W42104732202022 @default.
• W4210473220 countsByYear W42104732202023 @default.
• W4210473220 crossrefType "journal-article" @default.
• W4210473220 hasAuthorship W4210473220A5008566812 @default.
• W4210473220 hasAuthorship W4210473220A5028946644 @default.
• W4210473220 hasAuthorship W4210473220A5043895722 @default.
• W4210473220 hasAuthorship W4210473220A5045644790 @default.
• W4210473220 hasAuthorship W4210473220A5053324492 @default.
• W4210473220 hasAuthorship W4210473220A5058837514 @default.
• W4210473220 hasAuthorship W4210473220A5087015760 @default.
• W4210473220 hasAuthorship W4210473220A5089555041 @default.
• W4210473220 hasConcept C121608353 @default.
• W4210473220 hasConcept C126322002 @default.
• W4210473220 hasConcept C143998085 @default.
• W4210473220 hasConcept C197934379 @default.
• W4210473220 hasConcept C207103383 @default.
• W4210473220 hasConcept C2775930923 @default.
• W4210473220 hasConcept C2776694085 @default.
• W4210473220 hasConcept C2777511904 @default.
• W4210473220 hasConcept C2780110267 @default.
• W4210473220 hasConcept C44249647 @default.
• W4210473220 hasConcept C530470458 @default.
• W4210473220 hasConcept C71924100 @default.
• W4210473220 hasConcept C95190672 @default.
• W4210473220 hasConceptScore W4210473220C121608353 @default.
• W4210473220 hasConceptScore W4210473220C126322002 @default.
• W4210473220 hasConceptScore W4210473220C143998085 @default.
• W4210473220 hasConceptScore W4210473220C197934379 @default.
• W4210473220 hasConceptScore W4210473220C207103383 @default.
• W4210473220 hasConceptScore W4210473220C2775930923 @default.
• W4210473220 hasConceptScore W4210473220C2776694085 @default.
• W4210473220 hasConceptScore W4210473220C2777511904 @default.
• W4210473220 hasConceptScore W4210473220C2780110267 @default.
• W4210473220 hasConceptScore W4210473220C44249647 @default.
• W4210473220 hasConceptScore W4210473220C530470458 @default.
• W4210473220 hasConceptScore W4210473220C71924100 @default.
• W4210473220 hasConceptScore W4210473220C95190672 @default.
• W4210473220 hasLocation W42104732201 @default.
• W4210473220 hasLocation W42104732202 @default.
• W4210473220 hasOpenAccess W4210473220 @default.
• W4210473220 hasPrimaryLocation W42104732201 @default.
• W4210473220 hasRelatedWork W2063125980 @default.
• W4210473220 hasRelatedWork W2154590531 @default.
• W4210473220 hasRelatedWork W2171002327 @default.
• W4210473220 hasRelatedWork W2372740194 @default.

• next